InvestorsObserver
×
News Home

Does Twist Bioscience Corp (TWST) Have What it Takes to be in Your Portfolio Friday?

Friday, March 31, 2023 03:56 PM | InvestorsObserver Analysts

Mentioned in this article

Does Twist Bioscience Corp (TWST) Have What it Takes to be in Your Portfolio Friday?

Twist Bioscience Corp (TWST) is near the middle in its industry group according to InvestorsObserver. TWST gets an overall rating of 43. That means it scores higher than 43 percent of stocks. Twist Bioscience Corp gets a 41 rank in the Diagnostics & Research industry. Diagnostics & Research is number 57 out of 148 industries.

Overall Score - 43
TWST has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on TWST!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Twist Bioscience Corp Stock Today?

Twist Bioscience Corp (TWST) stock is trading at $14.91 as of 3:49 PM on Friday, Mar 31, a gain of $0.18, or 1.19% from the previous closing price of $14.73. The stock has traded between $14.81 and $15.50 so far today. Volume today is light. So far 832,084 shares have traded compared to average volume of 1,285,717 shares. Click Here to get the full Stock Report for Twist Bioscience Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App